CNS Disorders  >>  iloperidone  >>  Phase 4
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iloperidone / Generic mfg.
i-FANS, NCT01207414: Switching to Iloperidone From Other Antipsychotics in Schizophrenia

Completed
4
501
US
iloperidone, Fanaptâ„¢
Novartis
Schizophrenia
01/12
01/12
NCT01929889: Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia

Terminated
4
19
US
Iloperidone, Fanapt
Northwestern University, Novartis Pharmaceuticals
Schizophrenia, Schizoaffective Disorder
02/14
10/14
IMPACT, NCT00806234: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics

Completed
4
127
US
Aripiprazole or Perphenazine, Abilify, Trilafon, Metformin, Glucophage, Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine, Zyprexa, Seroquel, Risperdal, Geodon, Abilify, Saphris, Sycrest, Fanapt, Fanapta, Zomaril, Latuda, Invega, Symbyax
Johns Hopkins University, National Institute of Mental Health (NIMH), University of Maryland, University of North Carolina, Chapel Hill, The Zucker Hillside Hospital
Psychotic Disorders
03/14
03/14
NCT01920802: Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo

Completed
4
31
US
olanzapine, Zyprexa, iloperidone, Fanapt, Placebo
New York State Psychiatric Institute, Novartis Pharmaceuticals
Healthy
08/14
09/14
NCT01464229: Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability

Completed
4
20
US
Iloperidone, Placebo
Maurizio Fava, MD, Novartis Pharmaceuticals
Major Depressive Disorder
12/14
12/14
NCT02413918: Iloperidone in Mixed States of Bipolar Disorder

Completed
4
41
US
iloperidone, Fanapt
The University of Texas Health Science Center at San Antonio, Novartis Pharmaceuticals, Vanda Pharmaceuticals
Bipolar Disorder
04/15
04/15
NCT05648591: Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Recruiting
4
100
US
Iloperidone, VYV-683, FANAPT
Vanda Pharmaceuticals
Schizophrenia, Bipolar I Disorder
09/24
09/24

Download Options